X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Strides Arcolab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs STRIDES SHASUN LTD - Comparison Results

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA STRIDES SHASUN LTD ELDER PHARMA/
STRIDES SHASUN LTD
 
P/E (TTM) x -0.2 34.4 - View Chart
P/BV x 0.1 0.9 11.0% View Chart
Dividend Yield % 0.0 1.1 -  

Financials

 ELDER PHARMA   STRIDES SHASUN LTD
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
STRIDES SHASUN LTD
Mar-17
ELDER PHARMA/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs3801,275 29.8%   
Low Rs188918 20.5%   
Sales per share (Unadj.) Rs491.2389.6 126.1%  
Earnings per share (Unadj.) Rs-3.228.0 -11.4%  
Cash flow per share (Unadj.) Rs14.448.9 29.5%  
Dividends per share (Unadj.) Rs04.50 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs376.5303.1 124.2%  
Shares outstanding (eoy) m20.5489.42 23.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.62.8 20.5%   
Avg P/E ratio x-89.339.2 -227.7%  
P/CF ratio (eoy) x19.722.4 87.9%  
Price / Book Value ratio x0.83.6 20.9%  
Dividend payout %016.1 0.0%   
Avg Mkt Cap Rs m5,83398,036 6.0%   
No. of employees `000NA5.8 0.0%   
Total wages/salary Rs m2,1795,881 37.1%   
Avg. sales/employee Rs ThNM6,005.9-  
Avg. wages/employee Rs ThNM1,014.0-  
Avg. net profit/employee Rs ThNM431.2-  
INCOME DATA
Net Sales Rs m10,08934,834 29.0%  
Other income Rs m2571,686 15.2%   
Total revenues Rs m10,34636,520 28.3%   
Gross profit Rs m-7926,428 -12.3%  
Depreciation Rs m3611,872 19.3%   
Interest Rs m2,7562,269 121.5%   
Profit before tax Rs m-3,6533,973 -91.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m04 0.0%   
Extraordinary Inc (Exp) Rs m3,713-1,006 -369.2%   
Tax Rs m125470 26.6%   
Profit after tax Rs m-652,501 -2.6%  
Gross profit margin %-7.818.5 -42.5%  
Effective tax rate %-3.411.8 -29.0%   
Net profit margin %-0.67.2 -9.0%  
BALANCE SHEET DATA
Current assets Rs m9,24038,165 24.2%   
Current liabilities Rs m9,99830,402 32.9%   
Net working cap to sales %-7.522.3 -33.7%  
Current ratio x0.91.3 73.6%  
Inventory Days Days4677 59.9%  
Debtors Days Days60104 57.4%  
Net fixed assets Rs m10,12437,639 26.9%   
Share capital Rs m206894 23.0%   
"Free" reserves Rs m5,58226,210 21.3%   
Net worth Rs m7,73427,105 28.5%   
Long term debt Rs m4,88916,377 29.9%   
Total assets Rs m22,88281,168 28.2%  
Interest coverage x-0.32.8 -11.8%   
Debt to equity ratio x0.60.6 104.6%  
Sales to assets ratio x0.40.4 102.7%   
Return on assets %11.85.9 200.1%  
Return on equity %-0.89.2 -9.2%  
Return on capital %22.312.1 185.1%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30713,465 2.3%   
Fx outflow Rs m1254,076 3.1%   
Net fx Rs m1819,389 1.9%   
CASH FLOW
From Operations Rs m11,7542,881 407.9%  
From Investments Rs m-561-7,051 7.9%  
From Financial Activity Rs m-6,7623,382 -199.9%  
Net Cashflow Rs m4,432-788 -562.7%  

Share Holding

Indian Promoters % 39.6 27.7 143.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 37.8 19.8%  
FIIs % 16.8 8.6 195.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 25.9 139.4%  
Shareholders   16,479 56,241 29.3%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   MERCK LTD  CIPLA  TORRENT PHARMA  SUVEN LIFE  WYETH LTD  

Compare ELDER PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens 99 Points Down; Vedanta & Coal India Top Losers(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.9% while the Hang Seng is down 2%. The Shanghai Composite is trading down by 2.7%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - WOCKHARDT LTD. COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS